Objective: The aim of our study was to determine whether eating behaviors and/or physical activity level may explain contradicting results in adipocytokines levels in anorexia nervosa (AN). Subjects/Methods: Fasting levels of circulating adipocytokines (adiponectin, resistin and leptin), insulin, glucose, C-reactive protein, cytokines (tumor necrosis factor-a and interleukin (IL)-1b), body composition and resting energy expenditure were measured in 24 women AN patients and 14 women controls. These parameters were compared according to AN subtypes: 15 patients with restrictive (R-AN) form versus 9 patients with binge/purge (BP-AN) form; 15 patients with hyperactive (H-AN) form versus 9 patients with nonhyperactive (NH-AN) form. Results: BP-AN patients had significantly higher serum adiponectin levels compared with R-AN patients (Po0.05), and H-AN patients had higher serum leptin and lower serum resistin levels compared with NH-AN patients (Po0.05 for both). Conclusions: Our study shows specific adipocytokines profiles depending on the subtype of AN: restrictive versus binge/purge and hyperactive versus Nonhyperactive forms. We suggest that these biological signatures could interfere with the outcome of the disease.
Introduction
Anorexia nervosa (AN) is a severe disease affecting mostly adolescent and adult women. This eating disorder is characterized by chronic self-starvation and is classically divided into two subtypes: the restrictive (R-AN) form and the binge/purge (BP-AN) form (Stoving et al., 1999; Thompson-Brenner et al., 2008) . AN patients may also be classified by the level of their physical activity: hyperactive (H-AN) form or nonhyperactive form (NH-AN). The consequences of such habits can lead to a life-threatening undernutrition. Indeed, the long-term mortality rate of this disease is significantly increased compared with age-matched control women (Lowe et al., 2001) .
Some adipocytokines secreted by adipose tissue, such as adiponectin, leptin and resistin, have major roles in the regulation of energy metabolism and/or insulin sensitivity (Zou and Shao, 2008) . The decrease of serum leptin levels constantly described in the literature was postulated to lead to both amenorrhea and restlessness similar to rat-specific semi-starvation-induced hyperactivity (Hebebrand et al., 2007) .
However, data concerning serum levels of the other adipocytokines are very conflicting. Serum adiponectin has been found to be either increased Pannacciulli et al., 2003) , normal (Iwahashi et al., 2003) or decreased (Tagami et al., 2004) in AN patients. Likewise, serum plasma resistin levels have been found to be either decreased (Dostalova et al., 2006) or normal (Dolezalova et al., 2007) . These discrepancies suggest that some confounding factors, such as eating behaviors and/or physical activity level, could interfere with the results. Accordingly, we compared circulating adipocytokines levels (leptin, adiponectin and resistin) between a group of women patients suffering from AN and a group of healthy control women and also between the different subtypes of the disease: R-AN versus BP-AN form or H-AN versus NH-AN form. Further, we assessed plasma proinflammatory cytokines (interleukin (IL)-1b and tumor necrosis factor-a (TNF-a)), which could be linked to eating behaviors, energy metabolism and adipocytokines levels (Brambilla, 2001) . We postulated that some clinical features of AN might lead to different adipocytokines profiles susceptible to interfere with the natural history of the disease. For example, hyperleptinemia during refeeding has been associated with an elevated risk of relapse in AN (Holtkamp et al., 2004b) .
Subjects and methods

Subjects
This study was conducted in accordance with the Declaration of Helsinki, approved by the institutional ethics committee and a written informed consent was obtained from all patients. Twenty-four women patients meeting the DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition) criteria of AN and referred to our nutrition department were included in the study (American Psychiatric Association, 1994) . Fifteen of them suffered from R-AN and nine from BP-AN according to the DSM-IV classification (American Psychiatric Association, 1994) . The mean frequency of vomiting and laxative abuse was once or twice per week. We defined the level of physical activity according to the Structured Interview of Anorexia and Bulimia Nervosa (SIAB) scale (Holtkamp et al., 2004a) . Fifteen patients were classified in the H-AN group (levels 3 and 4 on the SIAB scale), whereas nine patients were classified in the NH-AN group (levels 0-2 on the SIAB scale). Two patients were treated by antidepressant drugs, two by anxiolytic drugs, one by neuroleptic drugs, one by the association of antidepressant and anxiolytic drugs, two by the association of antidepressant and neuroleptic drugs, two by the association of antidepressant, anxiolytic and neuroleptic drugs, two by estroprogestative drugs and twelve patients received no drugs. In addition, 14 normal-weight healthy women were recruited as controls after a medical interview and a physical examination by a physician specialized in nutrition. None of them had any history of eating disorders or other psychiatric illness.
Methods
Blood samples were collected from each subject in the morning after an overnight fast at the first week of hospitalization in our nutrition department. Specific enzyme-linked immunosorbent assay (ELISA) kits were used to measure serum levels of leptin (Active Human Leptin, DSL Systems, Webster, TX, USA), adiponectin (Quantikine Human Adiponectin, R&D Systems, Minneapolis, MN, USA) and resistin (Quantikine Human Resistin, R&D Systems). Plasma C-reactive protein (CRP) was measured using the turbidimetric method (Synchron LX, Beckman Coulter, Paris, France). The plasma IL-1b and TNF-a levels were measured using ELISA kits (Human IL-1b/IL-1F2, R&D Systems; Human TNF-a/TNFSF1A Immunoassay, R&D Systems). Plasma glucose was measured using the hexokinase oxidase method (Beckman Coulter, Galway, Ireland) and plasma insulin levels through electrochemiluminescence (Roche Diagnostic, Mannheim, Germany). Insulin resistance was estimated using the homeostasis model assessment: HOMA-IR ¼ fasting insulin (mUI/l) Â fasting glucose (mmol/l)/22.5 (Matthews et al., 1985) .
Body composition was assessed using dual-energy X-ray absorptiometry method (Lunar iDXA, GE Healthcare, Chalfont, St Giles, UK): body fat mass (BFM) and body lean mass compartments were considered. Resting energy expenditure (REE) was measured by indirect calorimetry (Quark-RMR, Cosmed, Rome, Italy) after an overnight fast.
Statistical analysis
Statistical analysis was carried out using SPSS software (Statistical Package for the Social Sciences Inc, version 15.0, Chicago, IL, USA). The results are presented as means±s.d. The Mann-Whitney U-test was used for comparisons between groups. Multivariate model stepwise regression analyses were carried out in AN subgroups to determine associations of adipocytokines measures with different parameters. P-value o0.05 was considered statistically significant.
Results
Comparison between AN women patients and control subjects Characteristics of the AN women patients and the control women are presented in Table 1 . As expected, AN patients were leaner than control women (Po0.01).
The adipocytokines profiles in AN patients versus controls showed no difference in serum adiponectin and resistin levels, but there was a drastic decrease in the serum leptin level in AN patients (Po0.01). Plasma glucose was not different but plasma insulin was decreased (Po0.01), explaining the reduction of the HOMA-IR index in AN patients compared with controls (Po0.01). Plasma CRP and IL-1b levels did not differ between AN patients and control women, whereas plasma TNF-a was significantly lower in AN patients than in controls (Po0.05).
Comparison between R-AN and BP-AN patients
Results are presented in Table 2 .
Age, body mass index (BMI), body composition, REE, plasma CRP, IL-1b and TNF-a levels were not different between R-AN and BP-AN patients.
The significant difference between R-AN and BP-AN patients was the higher serum adiponectin levels in the BP-AN patients (Po0.05). There were no significant differences for serum resistin and leptin levels and HOMA-IR in R-AN compared with BP-AN patients.
In an additional stepwise multivariate analysis, when adjusted for plasma glucose, insulin, HOMA-IR, resistin, leptin, BMI, BFM, body lean mass, REE and binge/purge behaviors, only the BFM (b ¼ 0.70; Po0.05) and the presence of binge/purge behaviors (b ¼ 6.450; Po0.05) contributed positively and significantly to the variability of adiponectin and explained 66% of the serum adiponectin levels (r 2 ¼ 0.66).
Comparison between H-AN and NH-AN patients Results are presented in Table 2 . Age, BMI, body composition, REE, plasma CRP, IL-1b and TNF-a levels were not different between H-AN and NH-AN patients.
The H-AN patients showed significantly higher serum leptin levels and lower serum resistin levels compared with NH-AN patients (Po0.05 for both). Serum adiponectin levels were not different between the two groups of patients.
In an additional stepwise multivariate analysis, when adjusted for plasma glucose, insulin, HOMA-IR, adiponectin, BMI, BFM, body lean mass, REE and physical activity level, only the HOMA-IR (b ¼ 1.003; Po0.01) and the physical activity level (b ¼ 2.608; Po0.01) contributed positively and significantly, whereas the BFM (b ¼ À0.11; Po0.05) contributed negatively and significantly to the variability of leptin. These parameters contributed to 93% of the serum leptin levels (r 2 ¼ 0.93). Likewise, only the HOMA-IR (b ¼ 2.85;
Po0.05) contributed to the variability of resistin as a positive factor and explained 57% of the serum resistin levels (r 2 ¼ 0.57).
Discussion
This study confirmed the constant decrease of serum leptin levels seen in undernourished AN patients but shows specific adipocytokines profiles depending on the eating behaviors and the intensity of the physical activity. The comparison of these adipocytokines profiles was facilitated by the absence of difference in terms of age, BMI, body composition and REE between our subgroups of AN patients. The subgroup of BP-AN patients showed significantly higher adiponectin levels compared with R-AN patients. These results are not in agreement with the study of Housova et al. (2005) , which did not observe any difference between R-AN and BP-AN forms. Other studies showed an increase in serum adiponectin levels in AN but did not deal with AN subtypes Pannacciulli et al., 2003) . However, it is noteworthy that Monteleone et al. (2003) documented a significant increase of circulating adiponectin levels in patients with bulimia nervosa and a correlation of this increased adipocytokine secretion with the frequency of binge/purge episodes. The physiological relevance of the plasma adiponectin increase in AN remains unclear and is still debated. The hyperadiponectinemia could contribute to etiopathogenic factor of AN (Housova et al., 2005) , or on this background of AN with lower plasma insulin levels, could represent a compensatory mechanism for the increase of insulin sensitivity (Monteleone et al., 2008) . Indeed, a negative correlation has been found between plasma adiponectin and insulin levels in AN (Dostalova et al., 2007) . However, we did not find a significant difference in insulin sensitivity between the AN patient subtypes.
The most interesting finding of this study is the adipocytokines profile of H-AN patients showing a higher level of serum leptin and a lower level of serum resistin compared with NH-AN patients.
The results of serum leptin levels do not support the hypothesis from Hotkamp's group that low leptin levels in AN can facilitate motor restlessness and intensive exercise behaviors as observed during the semi-starvation-induced hyperactivity model in rodents (Hebebrand et al., 2003; Holtkamp et al., 2006) . However, in this study, the relationship between serum leptin levels and physical activity follows an inverted U-shape curve; physical activity levels are lower in severely undernourished AN patients leading to the hypothesis that the effect of hypoleptinemia on physical activity levels declines with the severity of the undernutrition (Holtkamp et al., 2006) . In our study, the mean BMI and the mean serum leptin levels of the AN patients were lower than in this previous study (Holtkamp et al., 2006) .
The intensity of physical activity is rarely taken into account as a predicting factor for the outcome in AN (Davis et al., 1997) . However, in a large multicentric European study, periodic overactivity was a significant predictor of readmission in a multivariate analysis (Steinhausen et al., 2008) . This parameter was a stronger predictor of relapse than purge habits, classically a worsening prognostic factor, which did not reach the statistically significant level. Periodic overactivity multiplied the risk of readmission by a factor of 2.51 (Steinhausen et al., 2008) . Serum leptin levels increased with the recovery of body weight, but hyperleptinemia during refeeding could contribute, through its effects on appetite suppression and energy expenditure, to the difficulties in reaching and maintaining the target weight and is associated with an elevated risk of renewed weight loss in AN (Holtkamp et al., 2004b) . Although the serum leptin levels of the H-AN patients are low compared with the control subjects, the relative increase of these hormone levels in this H-AN group compared with the NH-AN patients could contribute to the worse outcome observed in H-AN patients. This is the first study showing a decrease of serum resistin levels in H-AN patients compared with NH-AN patients, despite the fact that we found no difference in serum resistin values in the whole AN group compared with healthy control women, as seen in other studies (Housova et al., 2005) . The H-AN patients tend to be more insulin sensitive than the NH-AN patients. The decrease of serum resistin levels in H-AN patients was associated positively with HOMA-IR. Consistent with our observations, Rubin et al. (2008) in normal-weight adolescents boys and Jones et al. (2009) in overweight adolescents previously showed that vigorous physical activity is associated with lower serum resistin levels, suggesting a link between insulin sensitivity and resistin secretion; physical activity having a moderator role in this relationship.
In humans, it is well known that resistin positively regulates proinflammatory factors. However, in our study, there was no link between serum resistin levels and the concentrations of major proinflammatory cytokines, such as TNF-a and IL-1b. The data on production of proinflammatory cytokines in AN patients are very conflicting. We found a decrease in the levels of plasma TNF-a that is consistent with another study (Nova et al., 2002) . However, these results are not in accordance with other previous studies showing normal or increased (Nakai et al., 1999) plasma TNF-a values. In AN, serum resistin levels seem not to be linked to inflammatory status, but are more likely associated to insulin sensitivity in the H-AN form.
To date, the concept of subtypes in AN, which could be relevant in terms of psychological background and prognosis is still debated. Indeed, some authors advocate for spiting the AN in subgroups (Eddy et al., 2002) and others contest the accuracy of such classifications, arguing that the various clinical presentations could simply represent distinct steps in a common natural history of the disease (Eddy et al., 2002) .
In conclusion, we showed specific adipocytokines profiles corresponding to different forms of AN: increased serum leptin together with decreased serum resistin levels associated with the H-AN form and hyperadiponectinemia associated with BP-AN form. Further studies are needed to confirm our results and elucidate whether these specific hormone profiles are secondary to the nutritional status of the AN patient and/or could interfere with the subtype or the natural history of the disease. We pointed out the importance of the different forms of AN, taking into account eating behaviors as well as physical activity level and suggest that this subclassification is relevant not only in terms of clinical features but also corresponds to a specific biological signature.
